Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Sarcoma 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Oligodendroglioma 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hepatoblastoma 1Gliosarcoma 1Glioma 1Glioblastoma 1Ependymoma 1Dermatofibrosarcoma 1Brain Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 56fludarabine phosphate 40Peripheral Blood Stem Cell Transplantation 32Cyclosporine 32Filgrastim 31Busulfan 31Mycophenolic Acid 30Antilymphocyte Serum 28Radiotherapy 27Whole-Body Irradiation 25Melphalan 23Tacrolimus 18Methylprednisolone 18Cord Blood Stem Cell Transplantation 17Methotrexate 16Etoposide 16Cytarabine 9Thiotepa 8sargramostim 6fludarabine 6aldesleukin 6Sirolimus 6Rituximab 6thymoglobulin 5Therapeutics 5Psychiatric Rehabilitation 5Granulocyte Colony-Stimulating Factor 5Doxorubicin 4Vincristine 3Prednisone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma × MLN 8237 × Sarcoma × Clear all
NCT01154816 2020-05-13

Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia

Children's Oncology Group

Phase 2 Completed
118 enrolled 24 charts
CNSGastrointestinalLymphoidOther hematologic neoplasmSarcoma

Neuroblastoma, Osteosarcoma, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡